Known Uses Only (No New Predictions)
For these drugs, every candidate from the TxGNN model is already a known use (recorded in the knowledge graph or in a medicine licence), so there is no new predicted indication. Each page lists the known uses and the local market status.
33 drugs
| Drug | Report |
|---|---|
| Abemaciclib | View page |
| Acetaminophen | View page |
| Aluminum Hydroxide | View page |
| Apraclonidine | View page |
| Betaxolol | View page |
| Brinzolamide | View page |
| Brompheniramine | View page |
| Carteolol | View page |
| Dexchlorpheniramine | View page |
| Diltiazem | View page |
| Eptinezumab | View page |
| Erenumab | View page |
| Flurazepam | View page |
| Ixekizumab | View page |
| Lemborexant | View page |
| Levobunolol | View page |
| Niacin | View page |
| Obinutuzumab | View page |
| Olaparib | View page |
| Olodaterol | View page |
| Ozanimod | View page |
| Pilocarpine | View page |
| Rabeprazole | View page |
| Silicon Dioxide | View page |
| Sumatriptan | View page |
| Suvorexant | View page |
| Temazepam | View page |
| Teriflunomide | View page |
| Tiagabine | View page |
| Tirzepatide | View page |
| Trastuzumab Emtansine | View page |
| Triazolam | View page |
| Trospium | View page |